1. Home
  2. MCRB vs MGYR Comparison

MCRB vs MGYR Comparison

Compare MCRB & MGYR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Seres Therapeutics Inc.

MCRB

Seres Therapeutics Inc.

HOLD

Current Price

$9.42

Market Cap

139.7M

Sector

Health Care

ML Signal

HOLD

Logo Magyar Bancorp Inc.

MGYR

Magyar Bancorp Inc.

N/A

Current Price

$17.92

Market Cap

115.2M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
MCRB
MGYR
Founded
2010
1922
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Savings Institutions
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
139.7M
115.2M
IPO Year
2015
2021

Fundamental Metrics

Financial Performance
Metric
MCRB
MGYR
Price
$9.42
$17.92
Analyst Decision
Hold
Analyst Count
3
0
Target Price
$14.33
N/A
AVG Volume (30 Days)
46.0K
8.0K
Earning Date
06-08-2026
01-01-0001
Dividend Yield
N/A
2.27%
EPS Growth
N/A
26.83
EPS
0.64
0.50
Revenue
$789,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$14.28
$35.84
Revenue Growth
N/A
N/A
52 Week Low
$0.36
$13.52
52 Week High
$29.98
$20.00

Technical Indicators

Market Signals
Indicator
MCRB
MGYR
Relative Strength Index (RSI) 43.72 55.05
Support Level $6.99 $17.07
Resistance Level $9.60 $18.96
Average True Range (ATR) 0.53 0.37
MACD 0.24 -0.01
Stochastic Oscillator 77.57 67.48

Price Performance

Historical Comparison
MCRB
MGYR

About MCRB Seres Therapeutics Inc.

Seres Therapeutics Inc is a microbiome therapeutics platform company operating in the United States. The company is engaged in developing biological drugs which are referred as ecobiotic microbiome therapeutics. The drugs discovered by the company are designed to restore health by repairing the function of a dysbiotic microbiome. The company focuses on implementing its microbiome therapeutics platform to develop ecobiotic microbiome therapeutics that treat dysbiosis in the colonic microbiome. SER-109, the company's product, is designed to prevent further recurrences of Clostridium difficile infection (CDI), a debilitating infection of the colon. In addition, the company is involved in developing SER-262, SER-287, and SER-401.

About MGYR Magyar Bancorp Inc.

Magyar Bancorp Inc is an independent, community financial services provider offering traditional banking services to individual, business, and government customers. The Company attracts retail deposits through its main office in New Brunswick, New Jersey, and branch offices in Middlesex and Somerset Counties, and invests those funds mainly in commercial and residential real estate loans, commercial business loans, SBA loans, home equity loans and lines of credit, construction and land loans, and investment securities. Revenues are derived mainly from interest on loans and securities and from fees and service charges, with lending relationships focused on small to mid-sized businesses and individual consumers in central and northern New Jersey.

Share on Social Networks: